Boston Scientific Corporation
Clinical trials sponsored by Boston Scientific Corporation, explained in plain language.
-
Stomach balloon helps shed pounds in new registry study
Disease control Recruiting nowThis study tracks 200 obese adults in the EU who choose to get the Orbera365 intragastric balloon for weight loss. Researchers will monitor serious side effects and how many people lose at least 10% of their total body weight over up to 12 months. The balloon is placed in the sto…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
New heart waveforms aim to tame atrial fibrillation
Disease control Recruiting nowThis study tests new energy waveforms from the FARAPULSE system to treat atrial fibrillation, a common heart rhythm problem. About 200 adults with either short-term or persistent AFib will receive the procedure. The goal is to see if the new waveforms can safely and effectively i…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
Real-World data sought on brain implant for hand tremors
Disease control Recruiting nowThis study is a registry that collects information on how well Boston Scientific's approved Deep Brain Stimulation (DBS) system works for people with essential tremor in everyday medical practice. Researchers will track changes in quality of life over time using a special questio…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
New device targets recurrent brain tumors without lifelong drugs
Disease control Recruiting nowThis study tests the safety of a device called TheraSphere GBM for people whose glioblastoma brain cancer has come back. About 36 adults will receive this treatment to see if it can control the tumor without needing long-term medication. The goal is to find a safer way to manage …
Phase: PHASE1 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
New registry tracks safety of Stroke-Prevention device in AF patients
Disease control Recruiting nowThis study is collecting real-world data on the WATCHMAN FLX Pro device, which is used to close off a part of the heart called the left atrial appendage in people with non-valvular atrial fibrillation. The goal is to reduce stroke risk without needing lifelong blood thinners. Abo…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
New heart pacing technique could improve life for heart failure patients
Disease control Recruiting nowThis study tests a newer way to pace the heart (left bundle branch area pacing, or LBBAP) against the standard method (cardiac resynchronization therapy, or CRT) in 850 adults with moderate to severe heart failure. The goal is to see if LBBAP reduces death, need for heart transpl…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
New pacemaker lead under study for heart rhythm problems
Disease control Recruiting nowThis study looks at a new way to pace the heart using a lead placed in the left bundle branch area. It aims to see if this method is safe and works well over time for people with a slow heart rate (bradycardia). About 140 adults who need a new pacemaker will take part. The study …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 00:29 UTC
-
Real-World test: are kidney stone & BPH devices safe?
Disease control Recruiting nowThis study monitors the safety and performance of Boston Scientific devices used to treat kidney stones and enlarged prostate (BPH). About 238 people will be followed after their procedure to track any serious side effects and how well the devices work. The goal is to confirm the…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Could a balloon replace stents in heart disease treatment?
Disease control Recruiting nowThis study compares a drug-coated balloon to standard stent treatment for people with coronary artery disease. About 1,600 participants will be randomly assigned to receive either the balloon or a stent during a procedure to open blocked heart arteries. The goal is to see if the …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Does a Stomach-Stitching procedure keep weight off for 5+ years?
Disease control Recruiting nowThis study looks at whether people who had a procedure called endoscopic sleeve gastroplasty (ESG) to help with obesity keep the weight off for five years or more. Researchers will follow 100 adults who had ESG at least five years ago to measure their weight loss. The goal is to …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Sponge treatment may seal dangerous Post-Surgery leaks
Disease control Recruiting nowThis study tests a sponge-based treatment called Endo-SPONGE for people who develop a leak after colorectal surgery. The sponge is placed inside the leak during an endoscopic procedure to help it heal. Researchers will check if the leak closes within 3 months without needing more…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New heart catheter aims to zap away irregular heartbeat
Disease control Recruiting nowThis study tests a new device called FARAFLEX that uses pulsed field ablation to treat people with persistent or occasional atrial fibrillation (an irregular heartbeat). About 250 adults will receive either the new catheter or a standard one to see if it safely and effectively cr…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New heart trial aims to improve rhythm control for persistent AF patients
Disease control Recruiting nowThis study compares two heart procedures for people with persistent atrial fibrillation (a type of irregular heartbeat). One group gets the standard treatment (pulmonary vein isolation) plus an extra step (linear ablation), while the other gets standard treatment alone. The goal …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New heart procedure aims to tame stubborn AFib
Disease control Recruiting nowThis study tests a new way to treat persistent atrial fibrillation (a type of irregular heartbeat) in people who have already had one ablation procedure. The treatment uses a special catheter to deliver targeted energy to the heart to fix the electrical problem. The study will en…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New registry tracks brain stimulation device for Parkinson's
Disease control Recruiting nowThis study is a registry that collects information from around the world on how well the Vercise deep brain stimulation (DBS) system works for people with Parkinson's disease. It will include up to 1,500 adults who are already eligible for this commercially available device. The …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Brain pacemaker for dystonia: 300-Patient study underway
Disease control Recruiting nowThis study tracks how well a commercially available deep brain stimulation system (Vercise) works for people with dystonia, a movement disorder causing muscle spasms. Researchers will follow 300 participants aged 7 and older to measure symptom reduction using standard rating scal…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for liver cancer patients: BSJ019T trial targets tumor control
Disease control Recruiting nowThis study is testing a treatment called BSJ019T in 51 Japanese adults with liver cancer that cannot be removed by surgery and has not responded to or is not eligible for standard treatments. The goal is to see if the treatment can control the cancer in the liver and to check for…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New hope for weight regain after gastric bypass: TORe procedure studied
Disease control Recruiting nowThis study looks at whether a procedure called TORe, combined with intensive lifestyle changes, helps people who have regained weight after gastric bypass surgery lose weight again. About 108 adults who regained at least 20% of their lost weight will be randomly assigned to eithe…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New heart procedure could improve treatment for persistent AF
Disease control Recruiting nowThis study compares two heart procedures for people with persistent atrial fibrillation (AF), a condition where the heart beats irregularly. Both procedures use pulsed field ablation to destroy small areas of heart tissue causing the problem. One group gets standard treatment plu…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New heart procedure tested in 500 chinese patients to control irregular heartbeat
Disease control Recruiting nowThis study is collecting real-world data on the FARAPULSE Pulsed Field Ablation system, a procedure that uses targeted energy to treat paroxysmal atrial fibrillation (an irregular heartbeat). About 500 adults in China will be followed for up to 3 years to see how well the treatme…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Double whammy: single procedure targets both AFib and stroke risk
Disease control Recruiting nowThis study combines two heart procedures into one session for people with atrial fibrillation (AFib). The first uses pulsed field energy to fix the irregular heartbeat, and the second closes a small pouch in the heart to lower stroke risk. About 433 adults who need both treatment…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
Pain device study tracks Real-World results for thousands
Disease control Recruiting nowThis study follows 4,800 adults who use a Boston Scientific neurostimulation system for pain. It aims to see how well the device works in everyday life over the long term. The study does not test a new treatment but observes real-world outcomes and costs.
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
New hope for weight loss after GLP-1 failure: stomach procedure vs. diet and exercise
Disease control Recruiting nowThis study looks at 150 adults with obesity who stopped taking popular weight-loss drugs (like Wegovy or Mounjaro) because of side effects or not losing enough weight. It compares two options: a minimally invasive procedure called endoscopic sleeve gastroplasty (ESG) that reduces…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Apr 26, 2026 19:36 UTC
-
New back pain procedure under Real-World study
Symptom relief Recruiting nowThis study is tracking how well a commercially approved procedure called Intracept works for people with chronic low back pain caused by a condition called vertebrogenic pain. The procedure uses a small device to treat the painful nerve inside the spine bone. Researchers will mea…
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 17, 2026 00:29 UTC
-
New spinal cord stimulation method aims to cut chronic pain in half
Symptom relief Recruiting nowThis study tests a new type of spinal cord stimulation (called TVP-SCS) in 70 adults with long-term back and leg pain that hasn't responded to other treatments. The goal is to see if this approach can reduce pain by at least 50% after 3 months. Participants will use a commerciall…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC
-
12,500 patients enrolled to monitor heart device safety
Knowledge-focused Recruiting nowThis study is a registry that collects information on the safety and performance of Boston Scientific heart devices, such as pacemakers and ablation tools, in up to 12,500 people. It does not test a new treatment or drug. Instead, it follows patients over time to track complicati…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 17, 2026 00:30 UTC
-
Real-World data sought on brain ablation for tremor and Parkinson's
Knowledge-focused Recruiting nowThis study is gathering information from 200 people with Parkinson's disease, dystonia, essential tremor, or other movement disorders who are already scheduled to receive radiofrequency (RF) ablation as part of their routine care. The goal is to see how this treatment affects qua…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC
-
New software aims to sharpen heart mapping in arrhythmia patients
Knowledge-focused Recruiting nowThis study tests new software features for mapping abnormal heart rhythms (arrhythmias) in 100 adults already scheduled for a standard catheter procedure. Doctors will provide feedback on how well the software works. The goal is to improve future versions of the mapping system, n…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 07, 2026 18:48 UTC
-
Brain pacemaker outcomes under review in 5,000 patients
Knowledge-focused Recruiting nowThis study will review the medical records of up to 5,000 people who have or are eligible for deep brain stimulation (DBS) to treat Parkinson's disease, essential tremor, or dystonia. Researchers want to see how well DBS improves symptoms over time in everyday medical practice. N…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC
-
Massive new registry tracks Real-World outcomes of Drug-Coated devices in leg artery disease
Knowledge-focused Recruiting nowThis study is a large registry that will collect information from 5,000 people with peripheral vascular disease who are treated with Boston Scientific drug-eluting devices in everyday medical practice. The goal is to gather real-world data on safety and effectiveness, including i…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 05, 2026 11:56 UTC
-
Researchers dig into medical records to uncover best pain relief methods
Knowledge-focused Recruiting nowThis study reviews anonymous medical records from 15,000 adults with chronic pain to see how well different treatments worked. No new treatments are given—researchers simply look back at what happened. The goal is to learn which approaches provide the best pain relief.
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 05, 2026 11:54 UTC